Clinical Trials Finder
Independent ClinicalTrials.gov directory
ClinicalTrials.gov record
Recruiting Phase 3 Interventional Results available

A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis

ClinicalTrials.gov ID: NCT04951622

Public ClinicalTrials.gov record NCT04951622. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search
ClinicalTrials.gov public records Last synced May 6, 2026, 8:25 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis

Study identification

NCT ID
NCT04951622
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Janssen Research & Development, LLC
Industry
Enrollment
199 participants

Conditions and interventions

Interventions

  • Nipocalimab Drug
  • Nipocalimab SC-LIV Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 14, 2021
Primary completion
Nov 16, 2023
Completion
Mar 29, 2029
Last update posted
Mar 2, 2026

2021 – 2029

United States locations

U.S. sites
24
U.S. states
15
U.S. cities
24
Facility City State ZIP Site status
Neuromuscular Research Center and Clinic Paradise Valley Arizona 85028 Recruiting
HonorHealth Neurology Scottsdale Arizona 85251 Completed
University of Southern California Los Angeles California 90033 Completed
Stanford University Palo Alto California 94304 Completed
Care Access Research Pasadena California 91101 Recruiting
University of Colorado Anschutz Medical Campus Aurora Colorado 80045 Recruiting
Yale New Haven Hospital New Haven Connecticut 06519 Recruiting
FM Clinical Research, LLC South Florida Neurology Associates, P. A. Boca Raton Florida 33487 Recruiting
University of Florida Health Jacksonville Jacksonville Florida 32209 Completed
Medsol Clinical Research Center Inc Port Charlotte Florida 33952 Recruiting
University of South Florida Tampa Florida 33612 Recruiting
Augusta University Augusta Georgia 30912-3125 Completed
University of Kansas Medical Center Kansas City Kansas 66160 Recruiting
St. Elizabeth Medical Center Boston Massachusetts 02135 Completed
Lahey Hospital & Medical Center Burlington Massachusetts 01805 Completed
Washington University School Of Medicine St Louis Missouri 63110 Completed
Duke University School of Medicine Durham North Carolina 27710 Recruiting
University of Cincinnati Cincinnati Ohio 45219 Completed
Cleveland Clinic Cleveland Ohio 44145 Recruiting
The Ohio State University Columbus Ohio 43210 Completed
Medical University of South Carolina Charleston South Carolina 29425 Recruiting
Wesley Neurology Cordova Tennessee 38018 Completed
UT Southwestern Medical Center Dallas Texas 75390 Completed
University of Vermont Burlington Vermont 05401 Completed

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 87 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04951622, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 2, 2026 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04951622 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →